(Q44126621)

30 November 2017

title

Effects of the selective dopamine D(1) antagonists NNC 01-0112 and SCH 39166 on latent inhibition in the rat. (English)

1 reference

30 November 2017

0 references

Karen M Trimble

1

1 reference

30 November 2017

Robert Bell

series ordinal

2

1 reference

30 November 2017

David J King

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

30 November 2017

published in

Physiology & Behavior

1 reference

30 November 2017

volume

77

1 reference

30 November 2017

issue

1

1 reference

30 November 2017

page(s)

115-123

1 reference

NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Differential performance of acute and chronic schizophrenics in a latent inhibition task.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Dopamine D1 (SCH 23390) and D2 (haloperidol) antagonists in drug-naive monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The effects of D1 (NNC 22-0215) and D2 (haloperidol) antagonists in a chronic double-blind placebo controlled trial in cebus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The effects of ritanserin, RU 24969 and 8-OH-DPAT on latent inhibition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Haloperidol enhancement of latent inhibition: Relation to therapeutic action?

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

An open trial of the D1 antagonist SCH 39166 in six cases of acute psychotic states.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Amphetamine-produced attenuation of latent inhibition is modulated by stimulus preexposure duration: implications for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Differential effects of the D1-DA receptor antagonist SCH39166 on positive and negative symptoms of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Latent inhibition is unaffected by direct dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Long-term attentional deficit in nonhandled males: possible involvement of the dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Effect of chronic treatment with NNC 756, a new D-1 receptor antagonist, or raclopride, a D-2 receptor antagonist, in drug-naive Cebus monkeys: dystonia, dyskinesia and D-1/D-2 supersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Abolition of latent inhibition by a single 5 mg dose of d-amphetamine in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

NNC 01-0687, a selective dopamine D1 receptor antagonist, in the treatment of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Lack of apparent antipsychotic effect of the D1-dopamine receptor antagonist SCH39166 in acutely ill schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Effects of the neuroleptic alpha-flupenthixol on latent inhibition in aversively- and appetitively-motivated paradigms: evidence for dopamine-reinforcer interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Extrapyramidal side effects of clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

A theory of attention: Variations in the associability of stimuli with reinforcement

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Clozapine: new research on efficacy and mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

MDL 73,147EF, a 5-HT3 antagonist, facilitates latent inhibition in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The pharmacology of latent inhibition as an animal model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The effects of haloperidol and raclopride in the paw test are influenced similarly by SCH 39166

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The involvement of dopamine D1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Enhancement of latent inhibition in the rat by the atypical antipsychotic agent remoxipride.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Enhancement of latent inhibition in the rat at a high dose of clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Impact of SCH 23390 and SKF 83566, and functionally interactive D-1:D-2 receptor systems

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Neural substrates of latent inhibition: the switching model

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Facilitation of latent inhibition by haloperidol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The latent inhibition model of schizophrenic attention disorder and of antipsychotic drug action: comment on Dunn, Atwater and Kilts (Psychopharmacology, 1993, 112:315-323)

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The effects of the new antipsychotic, sertindole, on latent inhibition in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Disruption of latent inhibition by acute administration of low doses of amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

The latent inhibition model of schizophrenia: further validation using the atypical neuroleptic, clozapine.

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

Increased dopamine release in vivo in nucleus accumbens and caudate nucleus of the rat during drinking: a microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0031-9384%2802%2900814-4

7 January 2021

10.1016/S0031-9384(02)00814-4

Identifiers

DOI

1 reference

30 November 2017

1 reference